Success of HPV vaccination is now a matter of coverage

Lancet Oncol. 2012 Jan;13(1):10-2. doi: 10.1016/S1470-2045(11)70324-2. Epub 2011 Nov 8.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural
  • Comment

MeSH terms

  • Adenocarcinoma / prevention & control*
  • Adjuvants, Immunologic / administration & dosage*
  • Aluminum Hydroxide / administration & dosage*
  • Female
  • Human papillomavirus 16 / immunology*
  • Human papillomavirus 18 / immunology*
  • Humans
  • Lipid A / administration & dosage
  • Lipid A / analogs & derivatives*
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / administration & dosage*
  • Precancerous Conditions / prevention & control*
  • Uterine Cervical Dysplasia / prevention & control*
  • Uterine Cervical Neoplasms / prevention & control*

Substances

  • ASO4 mixture
  • Adjuvants, Immunologic
  • Lipid A
  • Papillomavirus Vaccines
  • human papillomavirus vaccine, L1 type 16, 18
  • Aluminum Hydroxide